日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PD118 Company-Led Submissions For Cancer Medicines: The Singapore Experience

PD118 公司主导的癌症药物申报:新加坡的经验

Vogler, Sabine; Zimmermann, Nina; Leopold, Christine; de Joncheere, Kees; Ong, Jiamin; Loke, Lydia; Lin, Liang; Ng, Kwong

Global consumption of prescription opioid analgesics between 2009-2019: a country-level observational study

2009-2019年全球处方阿片类镇痛药消费情况:一项国家层面的观察性研究

Jayawardana, Sahan; Forman, Rebecca; Johnston-Webber, Charlotte; Campbell, Allen; Berterame, Stefano; de Joncheere, Cees; Aitken, Murray; Mossialos, Elias

Patent pooling to increase access to essential medicines

利用专利池增加基本药物的可及性

Burrone, Esteban; Gotham, Dzintars; Gray, Andy; de Joncheere, Kees; Magrini, Nicola; Martei, Yehoda M; Gore, Charles; Kieny, Marie Paule

Essential medicines for universal health coverage

全民健康覆盖的基本药物

Wirtz, Veronika J; Hogerzeil, Hans V; Gray, Andrew L; Bigdeli, Maryam; de Joncheere, Cornelis P; Ewen, Margaret A; Gyansa-Lutterodt, Martha; Jing, Sun; Luiza, Vera L; Mbindyo, Regina M; Möller, Helene; Moucheraud, Corrina; Pécoul, Bernard; Rägo, Lembit; Rashidian, Arash; Ross-Degnan, Dennis; Stephens, Peter N; Teerawattananon, Yot; 't Hoen, Ellen F M; Wagner, Anita K; Yadav, Prashant; Reich, Michael R

Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis

30个国家丙型肝炎新药的价格、成本和可负担性:一项经济分析

Iyengar, Swathi; Tay-Teo, Kiu; Vogler, Sabine; Beyer, Peter; Wiktor, Stefan; de Joncheere, Kees; Hill, Suzanne

Cost-effectiveness thresholds: pros and cons

成本效益阈值:利弊分析

Bertram, Melanie Y; Lauer, Jeremy A; De Joncheere, Kees; Edejer, Tessa; Hutubessy, Raymond; Kieny, Marie-Paule; Hill, Suzanne R

Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference

危机中的药品政策?PPRI会议上提出的挑战和解决方案

Vogler, Sabine; Zimmermann, Nina; Ferrario, Alessandra; Wirtz, Veronika J; de Joncheere, Kees; Pedersen, Hanne Bak; Dedet, Guillaume; Paris, Valérie; Mantel-Teeuwisse, Aukje K; Babar, Zaheer-Ud-Din

The Pharmaceutical Pricing and Reimbursement Information (PPRI) network – a decade of exchange of information and policy research?

药品定价和报销信息(PPRI)网络——十年来的信息交流和政策研究?

Yao, Yancheng; Imirzalioglu, Can; Falgenhauer, Linda; Chakraborty, Trinad; Vogler, Sabine; Zimmermann, Nina; De Joncheere, Kees

Tough decisions on essential medicines in 2015

2015年关于基本药物的艰难抉择

Magrini, Nicola; Robertson, Jane; Forte, Gilles; Cappello, Bernadette; Moja, Lorenzo P; de Joncheere, Kees; Kieny, Marie-Paule

Medicines availability for non-communicable diseases: the case for standardized monitoring

非传染性疾病药物可及性:标准化监测的必要性

Robertson, Jane; Macé, Cécile; Forte, Gilles; de Joncheere, Kees; Beran, David